Bcl-2 family members act as important prognostic factors in AML; the inhibition of Bcl-2 expression induces apoptosis and sensitizes AML cells to chemotherapy via regulation of mitogen-activated protein kinase pathway, a key integration point in the signaling cascade regulated by growth factor receptors. This evidence concerns the gene WNK2 and acute myeloid leukemia.